FDA inspection
Apotex Inc.: FDA inspection ending May 9, 2025
FDA inspection 1269863 · Voluntary Action Indicated (VAI) · Brantford
Key facts
| Inspection ID | 1269863 |
|---|---|
| Firm | Apotex Inc. |
| FEI number | 3000114091 |
| Address | 34 Spalding Dr |
| City | Brantford |
| Country | Canada |
| Fiscal year | 2025 |
| Inspection end date | May 9, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 714137 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data